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Abstract: Occupational and environmental exposure to cadmium is associated with the 15 
development of urothelial cancer. The metallothionein (MT) family of genes encodes proteins that 16 
sequester metal ions and modulate physiological processes, including zinc homeostasis. Little is 17 
known about the selectivity of expression of the different MT isoforms. Here, we examined the effect 18 
of cadmium exposure on MT gene and isoform expression by normal human urothelial (NHU) cell 19 
cultures. Baseline and cadmium-induced MT gene expression was characterized by next generation 20 
sequencing and RT-PCR; protein expression was assessed by western blotting using isoform-21 
specific antibodies. Expression of the zinc transporter-1 (SLC30A1) gene was also assessed. NHU 22 
cells displayed transcription of MT-2A, but neither MT-3 nor MT-4 genes. Most striking was a highly 23 
inducer-specific expression of MT-1 genes, with cadmium inducing transcription of MT-1A, MT-1G, 24 
MT-1H and MT-1M. Whereas MT-1G was also induced by zinc and nickel ions and MT-1H by iron, 25 
both MT-1A and MT-1M were highly cadmium-specific, which was confirmed for protein using 26 
isoform-specific antibodies. Protein but not transcript endured post exposure, probably reflecting 27 
sequestration. SLC30A1 transcription was also affected by cadmium ion exposure, potentially 28 
reflecting perturbation of intracellular zinc homeostasis. We conclude that human urothelium 29 
displays a highly inductive profile of MT-1 gene expression, with two isoforms identified as highly 30 
specific to cadmium providing candidate transcript and long-lived protein biomarkers of cadmium 31 
exposure. 32 
Keywords: Metallothionein, urothelium, urothelial cancer, cadmium exposure, zinc transporter 33 
 34 
1. Introduction 35 
Occupational and environmental exposure to cadmium has increased as a result of the burning 36 
of fossil fuels and widespread use of the heavy metal in anthropological activities, such as battery 37 
production, electroplating, smelting and soldering (reviewed [1]). Cadmium ions accumulate in the 38 
body in an almost irreversible manner [2], as the metal cannot be metabolized to a less toxic species 39 
[3] and has a low excretion rate [4]. This is thought to be due to intracellular sequestration of cadmium 40 
ions by metal-binding proteins [5Ȯ7]. An association between cadmium exposure and bladder 41 
(urothelial) carcinogenesis has been reported, with higher cadmium concentrations demonstrated in 42 
the blood [8] and urine [9Ȯ11] of patients with bladder cancer. In vitro research supports these 43 
correlative studies, with malignant transformation of the immortalized RWPE-1, TLR1215, 16HBE 44 
and UROtsa cell lines reported after extended chronic cadmium exposure [12Ȯ15]. The bladder stores 45 
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concentrated urine prior to voiding, meaning that the urothelial lining of the bladder, which functions 46 
as one of the tightest epithelial barriers [16], is potentially exposed to excreted xenobiotics [16Ȯ18]. It 47 
is not known whether exposure to urinary cadmium is limited by the presence of an intact urinary 48 
barrier.  49 
The metallothioneins (MTs) are a superfamily of low-molecular weight (~6 kDa), cysteine-rich 50 
proteins that are induced by and bind a range of metal ions, including cadmium [19,20]. Through this 51 
sequestration of metal ions MTs are considered to play a primary role in metal detoxification [21,22], 52 
but also metal (e.g. zinc) homeostasis [23Ȯ25] and the scavenging of reactive oxygen species (ROS) 53 
[26,27]. MT involvement in the bodily response to cadmium exposure has been well-documented, 54 
with numerous studies demonstrating cadmium-induced MT expression both in vitro [28Ȯ34] and in 55 
vivo [35,36].  56 
Direct binding of MT protein to cadmium ions [37,38] results in a MT-cadmium complex that is 57 
highly resistant to degradation [5Ȯ7]. In man, four main MT subfamilies exist (MT-1, MT-2/2A, MT-3 58 
and MT-4), with MT-1 consisting of nine isoforms (-A, -B, -E, -F, -G, -H, -L, -M, -X) [39] each encoded 59 
on individual genes. It is predicted that the individual MT isoforms have distinct properties including 60 
structure [40-41], tissue- and inducer-specific expression [22,34,42Ȯ47], induction rate [48], 61 
translational efficiency [41] and degradation rate [49,50]. Cadmium is reported to be the most potent 62 
inducer of MT expression [51]. This offers the potential that individual MT isoforms may be utilized 63 
as specific biomarkers of human exposure to cadmium, although it remains unclear which isoform(s) 64 
are responsible for cadmium sequestration. This lack of discrimination is largely due to the high 65 
homology between isoforms and the lack of discriminatory reagents, with no validated antibodies 66 
able to distinguish MT-1 and MT-2 subfamilies, nor the different MT-1 isoforms [41,52].   67 
MTs are reported to work cooperatively with zinc transporters to regulate cellular zinc 68 
homeostasis, potentially by modulating cellular zinc ion concentration [39], although the exact 69 
mechanisms are unknown. Thus, a possible consequence of exposure to cadmium ions may be altered 70 
cellular zinc homeostasis. Cadmium and zinc possess highly similar properties, and it has been 71 
shown that cadmium can substitute for zinc in biological systems [53]. This can disrupt the normal 72 
functioning of various biological pathways [54,55], thus indirectly influencing processes involved in 73 
carcinogenesis such as cell proliferation and metastasis [56].   74 
Our aims were to investigate MT isoform expression and specificity of induction in human 75 
urothelium under baseline and cadmium-exposed conditions, using a well-characterised normal 76 
human urothelial (NHU) cell culture system that includes polarized differentiated NHU cell sheets 77 
possessing tight barrier function [57,58]. Prior to cadmium exposure, cellular growth assays were 78 
performed to assess cytotoxicity. We next exposed NHU cells to a variety of potential MT inducers, 79 
including reactive oxygen species (ROS) [59,60], essential metals [44,61Ȯ66] and heavy metals [67Ȯ70] 80 
to define the specificity of response. Previously unpublished MT-1 isoform-specific antibodies were 81 
used to discriminate between MT-1 isoform proteins. Lastly, we determined whether transcription of 82 
the free zinc efflux regulator, zinc transporter-1 (SLC30A1) [71], altered as a consequence of cadmium 83 
exposure. These results revealed that MT isoform expression was inducer-specific and that 84 
abundance of both MT-1A and MT-1M transcript and protein was highly cadmium-specific, 85 
highlighting their potential as biomarkers of exposure. Cadmium was able to penetrate an intact 86 
urothelial barrier and effected transcriptional upregulation of SLC30A1, indicating a potential route 87 
for cadmium uptake and subsequent substitution in zinc homeostatic mechanisms.   88 
 89 
2. Results 90 
2.1 Influence of cadmium on NHU cell culture growth and uptake of cadmium across an intact urothelial 91 
barrier 92 
Exposure of non-differentiated NHU cells to cadmium revealed that cell growth was unaffected 93 
by concentrations ǂ10 µM CdCl2 whilst exposure to 20 µM CdCl2 resulted in distinct cytotoxicity (Fig 94 
1A). Replication in a second independent cell line confirmed that exposure to 10 µM CdCl2 did not 95 
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affect NHU cell growth (Fig 1B) and this concentration was therefore selected for further experiments. 96 
When differentiated NHU cell cultures (three independent cell lines) were grown on permeable 97 
membranes in triplicate and exposed apically to 10 µM CdCl2 for 72 hours, no effect was seen on 98 
barrier function (control versus cadmium-exposed transepithelial electrical resistance (TEER) of 3.24 99 
ƹȱŖǯŚŞȱA?ǯ2 ȱřǯŗŝȱƹȱŖǯśŘȱA?ǯ2, mean ± SEM; P=0.93; Table S1). The barrier was retained 100 
during CdCl2 exposures of at least 7 days, over which time the TEER increased in the cadmium-101 
exposed culture to 1.8 fold over control. Analysis of cell lysates by inductively coupled plasma optical 102 
emission spectroscopy (ICP-OES) revealed an intracellular ȱ ȱ ȱ ŖǯşŚȱAgȱ ȱ103 
lysates from cadmium-¡ȱȱȱȱŖǯŖŞȱAgȱȱȱtures. 104 
 105 
 106 
Figure 1. Biomass growth assays for in vitro NHU cell cultures exposed to cadmium. AlamarBlue® assays 107 
were performed over 7 days on NHU cell cultures seeded at 6 x 104 cells/cm2. (A) NHU cells were exposed 108 
to a range of cadmium concentrations from 0 to 20 µM (n=1 independent cell line). Each data point 109 
represents mean percentage reduction in AlamarBlue® ±S.D. from three replicate cultures. (B) NHU cells 110 
were exposed to 10 µM CdCl2 for up to 7 days. Data points represent mean percentage reduction in 111 
AlamarBlue® ±S.D. from two independent NHU cell lines, each performed in triplicate.   112 
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 113 
2.2 Baseline and cadmium-induced MT transcription in NHU cells 114 
NHU cells maintained in culture in non-differentiated and differentiated states were examined 115 
for baseline expression of MT genes. Analysis by mRNA-seq of non-differentiated NHU cells 116 
revealed high expression of MT-1E and MT-1X and low expression of MT-1A, MT-1B, MT-1F and 117 
MT-1G; there was no detection of MT-1H or MT-1M transcripts (Fig 2A). MT-2A expression was three 118 
times greater than all the MT-1 genes combined. No expression was detected for MT-3 or MT-4. In 119 
almost all cases where MT gene expression was detected in non-differentiated NHU cells, the 120 
expression was reduced in the differentiated state. This was most striking for MT-2A (log2FC=4.2; 121 
q=4.08x10-3) and MT-1E (log2FC=1.5; q=4.0x10-4), although between-donor variation prohibited 122 
statistical significance for many genes with lower expression. The apparent exception was MT-1X, 123 
where the average expression increased in the differentiated state. However, this was inconsistent 124 
between donors, and the differential expression was non-significant. Interestingly, MT-1L, which 125 
generates a transcript with a premature stop codon [72], was expressed at similar abundance to MT-126 
1E in the non-differentiated cells, but with a much greater downregulation in the differentiated state 127 
(log2FC=5.4; q=8.4x10-4). Previous reports of a truncation-rescuing polymorphism [73] was not 128 
identified in these donors, so while MT-1L is unlikely to form a functional protein, it may play a role 129 
in MT-1 transcript regulation. Expression was detected for SLC30A1 in both non-differentiated and 130 
differentiated states (Fig 2A), but there was no significant differentiation-associated change in 131 
expression. 132 
RT-PCR results supported the NGS data, although the variability in transcript detection in non-133 
differentiated NHU cells indicated a potentially inducible state (Fig 2B). Differentiated NHU cell 134 
cultures revealed a more consistent baseline expression of several MT-1 genes, particularly MT-1X 135 
(Fig 2C).   136 
Exposure to cadmium ions caused a massive induction of all eight MT-1 genes (MT-1A, MT-1B, 137 
MT-1E, MT-1F, MT-1G, MT-1H, MT-1M, MT-1X) within 12 hours of initial exposure, as demonstrated 138 
by the RT-PCR results, with expression receding over time (Figs 2B and 2C). Whereas expression of 139 
MT-1 transcripts was mostly lost after 48 hours of continuous cadmium exposure in non-140 
differentiated cell cultures (Fig 2B with independent cell line repeats in supplementary Figs S1 and 141 
S2), MT-1 subfamily transcript expression was still detectable in differentiated cell cultures after 72 142 
hours exposure (Fig 2C; with independent repeats in supplementary Figs S3 and S4).   143 
Irrespective of differentiation state and the presence or absence of cadmium, MT-2A transcript 144 
expression was constitutively high, whilst MT-3 and MT-4 transcripts were invariably absent.  Based 145 
on this, the MT-2A, MT-3 and MT-4 genes were not further studied. By contrast, the strong induction 146 
of the MT-1A, -1G, -1H and -1M paralogues, which was consistent following cadmium-exposure in 147 
three independent NHU cell lines, was further investigated for specificity. As the RT-PCR results 148 
demonstrated a striking on/off transcriptional response of the MT isoforms to cadmium exposure, it 149 
was decided to continue with this approach, as quantitative PCR would likely not have added 150 
anything to the data.  151 
 152 
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 154 
Figure 2. Baseline and cadmium-induced MT transcript expression by NHU cells in vitro. (A) Next 155 
generation sequencing data showing baseline MT isoform transcription in non-differentiated and 156 
differentiated NHU cells (n=3 independent cell lines; standard deviation is shown). (B-C) MT gene 157 
expression in NHU cells assessed by RT-PCR. The total cDNA input was 1 µg and PCR reaction products 158 
were removed after 25 cycles; GAPDH was included as input control. See Table 1 for primer sequences and 159 
product sizes. Note that medium was changed at time T=0 only and there was no renewal of cadmium over 160 
the period. The figure shows results representative of n=3 independent NHU cell lines. Additional PCR 161 
controls included genomic DNA as a positive control and a no-template (H2O) negative control; RT-ve 162 
samples confirmed absence of genomic contamination. 163 
x In B, the result of exposing non-differentiated NHU cells to different concentrations of cadmium (0-20 164 
AgM) for 72 hours on MT gene expression is shown.  165 
x In C, MT gene expression is shown in differentiated NHU cell cultures following exposure to 10 µM 166 
CdCl2 for up to 72 hours. 167 
 168 
2.3 Specificity of Cadmium-Induced MT Transcription  169 
NHU cell cultures were exposed to a variety of candidate MT inducers identified from the 170 
literature.   171 
ROS is reported as by-product of cadmium exposure [59] and we therefore sought to determine 172 
the effects of ROS on transcription of MT-1 genes. The ROS-inducing agent sulforaphane (C6H11NOS2) 173 
and ROS-inhibitor ascorbic acid (C6H8O6) were titrated against transcription of the ROS-sensitive 174 
heme oxygenase-1 (HMOX1) gene [74,75] to infer intracellular ROS activity (Figs 3A & 3B, 175 
respectively). Induction of expression of the four MT-1 genes in response to cadmium exposure was 176 
unaffected by 25 µg/mL ascorbic acid used to inhibit ROS, suggesting that ROS was not responsible 177 
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(Fig 3C). This conclusion was supported by the failure of 5 µM sulforaphane to induce MT-1 178 
expression (replicate in supplementary material, Fig S5).  179 
Differential induction of MT-1 paralogues was examined in response to other metal ions, both 180 
essential and carcinogenic (replicates in supplementary material, Figs S6 & S7). Both zinc and nickel 181 
exposure induced MT-1G transcription, whereas MT-1H transcript expression was only minimally 182 
induced by iron, and nickel had no effect. MT-1A transcription was constitutively low under all 183 
conditions apart from cadmium exposure, which increased expression, and MT-1M transcription was 184 
specifically induced by exposure to cadmium alone. 185 
 186 
 187 
 188 
Figure 3. Specificity of MT transcription induction by cadmium. MT gene expression was assessed by 189 
RT-PCR in NHU cells exposed to a variety of candidate inducers. The total cDNA input was 1 µg and PCR 190 
reaction products were removed after 25 cycles; GAPDH was included as input control. Note that medium 191 
was changed at time T=0 only and there was no renewal of treatments over the period. Additional PCR 192 
controls included genomic DNA as a positive control and a no-template (H2O) negative control; RT-ve 193 
samples confirmed absence of genomic contamination. 194 
x In A, non-differentiated NHU cell cultures were treated with a range of concentrations of sulforaphane 195 
(C6H11NOS2) for 12 hours, and the effect on transcription of the ROS-sensitive gene HMOX1 assessed 196 
in comparison to exposure to 10 µM CdCl2 (n=1 independent cell line). The concentration of C6H11NOS2 197 
that induced transcription of HMOX1 to a comparable extent to cadmium was selected.  198 
x In B, non-differentiated NHU cell cultures were treated with a range of concentrations of ascorbic acid 199 
(C6H8O6) for 12 hours in combination with 10 µM CdCl2 and the effect on HMOX1 transcription 200 
assessed. The concentration of C6H8O6 that caused the biggest decrease in HMOX1 transcription was 201 
selected.  202 
x In C, NHU cell cultures (n=2 independent cell lines) were exposed to a range of candidate regulators 203 
and transcript expression was assessed for the MT-1 genes shown above to be most sensitive to 204 
cadmium induction (from Figures 2B & C). Candidate inducers tested were cadmium (10 µM CdCl2), 205 
cadmium combined with ascorbic acid (10 µM CdCl2 + 25 µg/mL C6H8O6), copper (10 µM CuSO4), iron 206 
(10 µM FeSO4), zinc (10 µM ZnCl2), arsenite (2 µM NaAsO2), nickel (200 µM NiCl2), and sulforaphane 207 
(5 µM C6H11NOS2). Essential metals were applied at equivalent concentrations to cadmium. Arsenite 208 
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and nickel were both used at their highest non-cytotoxic concentrations based on initial titration 209 
experiments (not shown). 210 
 211 
2.4 Immunoblotting with isoform-specific antibodies 212 
To examine if the observed induction of MT-1 gene expression translated to protein, antibodies 213 
specific to the MT-1A and MT-1M isoforms were used to perform western blotting. Control non-214 
differentiated NHU cells lacked MT-1A and MT-1M protein expression (Fig 4A). Cadmium exposure 215 
caused induction of both MT-1A and MT-1M proteins after 72 hours (replicate in supplementary 216 
material, S8). Both proteins were also induced in cadmium-exposed differentiated NHU cells (Fig 4B; 217 
replicate in supplementary material, S9). 218 
The specificity of MT-1A and MT-1M protein induction was examined in response to the wider 219 
range of candidate inducers. Western blotting revealed that the MT-1M isoform was induced only by 220 
cadmium exposure, supporting the RT-PCR results (Fig 4C; replicate in supplementary material, 221 
S10). MT-1A protein expression was highly induced by cadmium exposure, although low protein 222 
expression was observed under other conditions. As assessed by densitometry, only cadmium was 223 
capable of increasing MT-1A protein expression over control, resulting in a ~6-fold increase in MT-224 
1A protein expression (Fig 4D). 225 
 226 
 227 
Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW 8 of 27 
 
 228 
Figure 4. Western blot detection of cadmium-induced MT-1A and MT-1M expression in NHU cells 229 
using subtype-specific antibodies. MT-1A and MT-1M protein induction was observed by western 230 
blotting of NHU cells exposed to 10 µM CdCl2 for 72 hours. Total protein input was 20 µg per track, 231 
with A?-actin expression used to verify equal protein loading. Figures show western blots probed with 232 
MT-1A and MT-1M subtype-specific antibodies in (A) proliferating and (B) differentiated NHU cell 233 
cultures exposed to cadmium for 72 hours (representative blots shown from n=3 independent cell 234 
lines). In (B), differentiated barrier formation was confirmed by TEER (see Figure 3B). (C) Western 235 
blot showing specificity of MT-1A and MT-1M protein induction (representative of n=2 independent 236 
cell lines tested). Proliferating NHU cells were exposed to a range of potential inducers for 72 hours 237 
and protein expression assessed. The candidate inducers tested were cadmium (10 µM CdCl2), copper 238 
(10 µM CuSO4), iron (10 µM FeSO4), zinc (10 µM ZnCl2), arsenite (2 µM NaAsO2), nickel (200 µM 239 
NiCl2), and sulforaphane (5 µM C6H11NOS2). MT-1A protein expression is reported as fold-change 240 
relative to unexposed control cells.  241 
 242 
2.5 Upregulation of zinc transporter-1 (SLC30A1) transcription in cadmium-exposed NHU cells 243 
RT-PCR of both non-differentiated and differentiated NHU cells revealed that cadmium 244 
exposure resulted in increased SLC30A1 gene transcription compared to unexposed controls (Figure 245 
5A; replicate in supplementary material, S11). After cessation of exposure, SLC30A1 transcript 246 
expression receded over time, and this decrease was observed to occur most rapidly in non-247 
differentiated (after 24 hours; Figure 3B) compared to differentiated (after 11 days; Figure 5C) cell 248 
cultures.  249 
 250 
 251 
 252 
 253 
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Figure 5. Cadmium induction of zinc transporter-1 (SLC30A1) gene transcription. SLC30A1 gene 254 
transcript expression was assessed by RT-PCR, with PCR reaction products removed after 25 cycles. 255 
PCR controls included genomic DNA as a positive control and a no-template (H2O) negative control. 256 
Total cDNA input was 1 µg with GAPDH used as an input loading control; RT-ve samples confirmed 257 
the absence of genomic contamination. For differentiated NHU cells, differentiation was confirmed 258 
¢ȱȱȱȱȱǁŗŖŖŖȱA?ǯ2 (see supplementary materials, Table 1). 259 
x A: NHU cells in non-differentiated and differentiated states were maintained in control medium 260 
or with 10 µM CdCl2 for up to 72 hours.  Note that medium was changed at time T=0 and there 261 
was no renewal of the cadmium over the period. The figure shows representative results from 262 
n=3 (non-differentiated) and n=1 (differentiated) independent NHU cell lines.   263 
x B: RT-PCR of NHU cells in a non-differentiated state maintained in standard medium (control) 264 
or with 10 µM CdCl2 ȱȱ ȱŘŚȱȱȱ ȱ ȱ¡ȱ ǻȁ-¡ȂǼǰȱ ȱ265 
cadmium was removed from the medium (time point 0) and culture continued for a further 48 266 
hours.  267 
x C: RT-PCR of NHU cells in a differentiated state maintained in standard medium (control) or 268 
with 10 µM CdCl2 ȱȱȱřȱ¢ȱȱȱȱ¡ȱǻȁ-¡ȂǼ, whereupon cadmium 269 
was removed from the medium (time point 0) and culture continued for up to 11 days.  270 
 271 
3. Discussion 272 
ȱ ȱ Ȃȱ  ǰȱ ȱ ȱ ȱ ȱ ¢ȱ ȱ ȱ ȱ ȱ¡ȱ ȱ273 
urothelial tight barrier function. Previous studies have examined the effect of cadmium exposure on 274 
renal [76] and bronchial [77] epithelia, with both studies reporting a decrease or complete collapse of 275 
barrier function. By contrast, the results from this study showed that urothelial barrier function was 276 
retained and even tightened. This may reflect the type of epithelium being tested, as urothelial cells 277 
are known to form one of the tightest epithelial barriers in the human body and thus may be unique 278 
in their resistance to cadmium. Although cadmium did not compromise urothelial barrier function, 279 
our results found that apical exposure induced expression of MT-1 genes in underlying NHU cells 280 
and using ICP-OES, cadmium was detected in differentiated urothelial cell sheets. Taken together, 281 
these results indicate that the urothelium remains intact and may even mount a protective response 282 
to cadmium in terms of tight junction tightening, yet the heavy metal is able to penetrate the 283 
urothelial barrier.  284 
Also for the first time, we describe specific MT gene expression by normal human urothelium. 285 
Our results are consistent with previous reports in other tissues that MT-1 is the inducible subfamily 286 
[22,40,78], whereas MT-2A is the most widely expressed isoform, accounting for up to 50 % total MT 287 
expression in humans [6,79]. In agreement with the consensus that MT-3 is neural-restricted [80], we 288 
found no agents that could induce MT-3 transcription in urothelial cells. As an anomaly, one group 289 
has previously suggested a link between heavy metal exposure, MT-3 induction and urothelial 290 
carcinogenesis based on high MT-3 expression in malignant bladder cancer [81] and supported by in 291 
vitro studies in cadmium-transformed UROtsa cells [82,83]. However, we were not able to replicate 292 
those findings in our normal cell system.  293 
Of the MT-1 genes, transcription of MT-1F and MT-1G has previously been described as 294 
constitutive in human umbilical vein epithelial cells (HUVEC) under baseline conditions [42]. Both 295 
these genes exhibited low basal but inducible expression in NHU cells, therefore it cannot be certain 296 
whether the expression differences between tissues are constitutive, or due to inducers present in the 297 
culture medium. Whereas we found the majority of MT-1 paralogues to be inducible by cadmium 298 
exposure, transcript expression was transient, presumably due to sequestration leaving fewer free 299 
cadmium ions to maintain induction. By contrast, expression of MT-1 proteins was more stable and 300 
in line with the sequestering nature of the formed MT-cadmium complex. Previously, MT-1 protein 301 
isoform detection has been performed using mass-spectrometry [41], but the demonstrated 302 
Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW 10 of 27 
 
availability of specific antibodies now opens the door to detection using immunochemical 303 
approaches.  304 
Exposure of proliferating NHU cell cultures to a range of divalent metal ions revealed 305 
differential and inducer-specific induction of MT-1 isoforms. For example, zinc ions induced strong 306 
transcription of MT-1G, but not MT-1A genes, whereas nickel ions caused MT-1G expression 307 
exclusively.  Inducer-specific expression of MT-1 genes has been noted in other cell types [34,44Ȯ47], 308 
supporting the hypothesis that individual isoforms have very selective metal ion sequestering 309 
functions [5,6,22,39,40,84]. Western blotting revealed that cadmium was the most potent inducer of 310 
MT-1A protein expression, whereas MT-1M protein expression was highly specific to cadmium, 311 
revealing the potential of both as biomarkers of cadmium exposure. Neither arsenic nor nickel 312 
induced MT-1A or MT-1M expression, further demonstrating the specificity of MT-1 genes to 313 
differentiate between different non-genotoxic carcinogenic metals [85,86].  314 
Alongside a pathophysiological role in sequestering carcinogenic metals, the MTs are considered 315 
to contribute to the normal homeostasis of zinc, which, as a cofactor involved in many key cellular 316 
processes [56], is under tight control. MT sequestration and zinc transporter efflux coordinated by a 317 
common transcription factor MTF-1 [87] is thought to regulate the availability of zinc [88Ȯ91]. 318 
Changes in intracellular zinc concentration have been associated with tumour growth and 319 
progression [92].  The displacement of zinc from the proteome by cadmium may affect the 320 
intracellular concentration and/or availability of zinc ions and can substitute and destabilise the 321 
functional sites of zinc-containing proteins, such as zinc-finger transcription factors, changing the 322 
character and/or rendering them non-functional [54,55]. 323 
Preliminary investigation into the effect of cadmium exposure on zinc homeostasis in normal 324 
urothelial cells revealed an upregulation of the zinc transporter-1 (SLC30A1) gene transcript in non-325 
differentiated NHU cells. SLC30A1 upregulation was also observed in cadmium-exposed 326 
differentiated NHU cell sheets possessing a functional barrier, further suggesting that cadmium can 327 
penetrate an intact urothelial barrier. Such results agree with a previous study using the human 328 
hepatic HepG2 cell line, which demonstrated increased SLC30A1 protein expression and localization 329 
at the cell membrane after acute cadmium exposure [93]. A later study showed cadmium exposure 330 
resulted in a 93% increase in the intracellular labile zinc concentration, suggesting a large 331 
displacement of zinc ions from the proteome, possibly due to substitution by cadmium [94].   332 
ȱ¡ȱȱȱȱȱȱȁ-ȱ Ȃ as on the one hand, it functions to protect 333 
the cell, but by the same mechanisms can also facilitate malignant events [6,22,95,96]. MTs may 334 
contribute to cell survival by increasing resistance to ROS-induced apoptosis [97] and increasing 335 
cellular proliferation [32]. Cadmium exposure can result in inhibition of DNA repair [98], which 336 
coupled with increased cellular protection via cadmium-induced MT expression, increases the 337 
probability of deleterious cells surviving and passing on defects to their progeny [96]. The ability of 338 
MT to counteract ROS could also play a role in chemotherapy resistance, and high expression of MTs 339 
has been correlated with treatment resistance in bladder cancer [99,100]. Specifically, after radical 340 
surgery and adjuvant chemotherapy, 100% patients with high tumour MT expression progressed 341 
within nine months, whereas in patients with low MT expression, only 65% had progressed after five 342 
years [101].  343 
Our study supports a concordant induction of MT isoforms and SLC30A1 transcription in 344 
response to cadmium exposure. Whereas this does not directly contradict hypotheses that cadmium 345 
exposure increases cellular zinc concentration or that cellular zinc homeostasis is maintained through 346 
the cooperative regulation of MT and zinc transporters [39], it does proffer a more direct relationship 347 
with cadmium responsible for regulating SLC30A1 expression. This may reveal new insight as to the 348 
role of cadmium in (bladder) cancer, where previously reported SLC30A1 and MT changes may 349 
reflect increased concentrations of intracellular cadmium rather than zinc.  Our demonstration of 350 
differential MT-1 gene paralogue induction by zinc and cadmium should help design future (e.g. 351 
knockout) experiments to clarify the respective roles.  Further experiments might also directly 352 
quantify intracellular zinc in NHU cells after cadmium exposure and determine the consequences of 353 
cadmium on zinc homeostasis and dysregulated cadmium-substituted proteins.   354 
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  355 
4. Materials and Methods  356 
4.1 NHU cell culture and exposure to cadmium and other agents 357 
Normal human urothelial (NHU) cells were maintained in vitro as non-immortalised cell lines, 358 
as detailed elsewhere [57,102]. For routine culture, NHU cells were grown as adherent monolayers 359 
ȱ Ȝȱ  ȱ ǻȱ Ǽȱ ȱ low calcium [0.09 mM] keratinocyte serum-free 360 
medium (KSFM) containing bovine pituitary extract and recombinant epidermal growth factor (Life 361 
Technologies) supplemented with 30 ng/ml cholera toxin (KSFMc). NHU cell lines were sub-cultured 362 
by trypsinisation at just-confluence and used in experiments between passages 3-5.  363 
For cadmium exposure, medium was replaced with fresh medium containing 10 µM cadmium 364 
chloride (CdCl2). This concentration was selected after preliminary titration for toxicity (Figs 1A & 365 
1B). For other treatment agents, concentrations were selected following initial titration and target 366 
gene expression assessment (Figs 3A & 3B).  367 
NHU cell lines retain the capacity to differentiate to form a functional tight barrier epithelium 368 
(as described in [58]). Differentiation was induced by switching NHU cells into medium 369 
supplemented with 5% adult bovine serum for 5 days before sub-culture onto semi-permeable 370 
Ȝȱǻ	ȱ-One) membranes with a 0.4 µm pore size. After 24 hours, the exogenous 371 
calcium (Ca2+) concentration was increased to 2 mM (near physiological) and cultures were 372 
maintained for a further 7-9 days to develop a tight barrier. For cadmium exposure of differentiated 373 
NHU cell cultures, medium was removed from the apical chamber after establishment of a barrier 374 
ǁŗŖŖŖȱA?ǯ2 (see below) and replaced with fresh medium supplemented with 10 µM CdCl2, in order 375 
to mimic apical exposure. RNA and protein were then harvested from these membranes for further 376 
analysis. 377 
4.2 Measurement of transepithelial electrical resistance 378 
The barrier function of differentiated NHU cell sheets was assessed in triplicate cultures by 379 
ȱȱȱȱȱǻǼȱȱȱȜȱȱǻȱ380 
Precision Instruments), as described [103]. A blank (no cell) membrane measurement was subtracted 381 
from each TEER reading. 382 
4.3 MT transcript abundance quantification by next generation sequencing 383 
mRNA-seq data for three donor-matched NHU cultured non-differentiated and differentiated 384 
samples were previously generated by our group [104]ǯȱȱȱ ȱȁȂȱȱ385 
the Ensembl v.91 human transcriptome (GRCh38.p10) using kallisto v0.44.0 [105] and relative gene 386 
abundance was calculated as transcripts per million (TPM) following gene-level aggregation with 387 
tximport v1.8.0 [106]. Differentiation-associated expression changes in the MT gene family were 388 
detected by a differential-expression analysis conducted by sleuth [107] accounting for matched-389 
donor samples. Differentially-expressed genes are reported with their log2 transformed fold change 390 
(log2ǼȱȱȁȂȱȱǻ-Hochberg correction). 391 
4.4 Reverse transcriptase-polymerase chain reaction (RT-PCR)  392 
RT-PCR was performed to observe actual patterns of MT isoform induction (rather than relative 393 
change). RNA was extracted from cells using TRIzol® (ThermoFisher Scientific) and treated with a 394 
DNA-ȜȱȱǻǼǯȱȱ¢ȱ s performed on 1 µg RNA with random hexamers and 395 
the SuperScript®II First-Strand Synthesis System (Life Technologies).  PCR primers were designed 396 
specifically to detect all known splice variants for each MT-1 isoform gene, with GAPDH used as the 397 
internal transcript control [108]. Primer sequences and optimised PCR conditions are provided in 398 
Table 1. PCR was carried out in a T100 thermal cycler (Bio-Rad) using 25 reaction cycles.  Controls 399 
consisted of genomic DNA (gDNA as template positive control), water (no template control) and no 400 
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reverse transcriptase (gDNA negative control). PCR products were separated on 2 % (w/v) agarose 401 
gels, stained using SYBR® Safe DNA gel stain (Invitrogen) and visualised on a Gene Genius Gel 402 
Imaging System (Syngene). 403 
 404 
Table 1: Details of primers used for experiments. 405 
Target Gene Forward or Reverse Sequence (5´-3´) Product Size (bp) 
GAPDH Forward CAAGGTCATCCATGACAACTTTG 90 
GAPDH Reverse GGGCCATCCACAGTCTTCTG 90 
HMOX1 Forward CCAGCAACAAAGTGCAAGATTC 102 
HMOX1 Reverse GTGTAAGGACCCATCGGAGAAG 102 
MT-1A Forward CTCGAAATGGACCCCAACT 219 
MT-1A Reverse ATATCTTCGAGCAGGGCTGTC 219 
MT-1B Forward GGAACTCCAGGCTTGTCTTGG 77 
MT-1B Reverse TTGCAGGAGGTACATTTG 77 
MT-1E Forward TGCGCCGGCTCCTGCAAGTC 118 
MT-1E Reverse ATGCCCCTTTGCAGACGCAGC 118 
MT-1F Forward CCTGCACCTGCGCTGGTTCC 110 
MT-1F Reverse ACAGCCCTGGGCACACTTGC 110 
MT-1G Forward CTTCTCGCTTGGGAACTCTA 309 
MT-1G Reverse AGGGGTCAAGATTGTAGCAAA 309 
MT-1H Forward CCTCTTCTCTTCTCGCTTGG 317 
MT-1H Reverse GCAAATGAGTCGGAGTTGTAG 317 
MT-1M Forward CTAGCAGTCGCTCCATTTATCG 180 
MT-1M Reverse CAGCTGCAGTTCTCCAACGT 180 
MT-1X Forward GGACCCAACTGCTCCTGCTC 151 
MT-1X Reverse TTTGCAGATGCAGCCCTGGGC 151 
MT-2A Forward CCGACTCTAGCCGCCTCTT 259 
MT-2A Reverse GTGGAAGTCGCGTTCTTTACA 259 
MT-3 Forward AGTGCGAGGGATGCAAATG 98 
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MT-3 Reverse GCCTTTGCACACACAGTCCTT 98 
SLC30A1 Forward GCATCAGTTTATGAGGCTGGTCCT 352 
SLC30A1 Reverse CAGGCTGAATGGTAGTAGCGTGAA 352 
 406 
 407 
4.5 Western blotting 408 
NHU cell cultures were lysed into electrophoresis sample buffer containing protease inhibitors 409 
and sonicated. Twenty µg protein was resolved on 4-12% Bis-ȱȜȱ¢¢ȱȱ410 
(Invitrogen) in 2-(N-morphilino) ethanesulfonic acid (MES) buffer and electro-transferred onto 411 
polyvinylfluoride membranes (Millipore). Membranes were blocked with Odyssey® blocking buffer 412 
(LI-COR®), incubated with primary antibodies for 16 h at 4°C and bound antibody detected using 413 
Alexa Fluor® 680-conjugated anti-mouse secondary antibody (Invitrogen) or an IRDye 800-414 
conjugated anti-rabbit secondary antibody (Tebu-Bio). Antibody binding was visualised using an 415 
Odyssey® Sa Infrared Imaging System (LI-COR®). Protein quantification was performed using 416 
¢¢țȱȱȜȱ ȱśǯŖȱǻ-COR®). Details of antibodies are given Tables 2 and 3. 417 
 418 
Table 2: Details of primary antibodies used for experiments. 419 
Antigen Clone Host Supplier Dilution Molecular Weight (kDa) 
Beta-actin A5441 Mouse Sigma Aldrich 1:10 000 (WB) 42  
MT-1A B01P Mouse Abnova 1:750 (WB) 6  
MT-1M 17281-AP Rabbit ProteinTech 1 µg/mL (WB) 6 
 420 
Table 3: Details of secondary antibodies used for experiments. 421 
Antigen Conjugate Host Supplier Application 
Anti-mouse IgG Alexa 680 Goat Life Technologies WB 
Anti-rabbit IgG Alexa 800 Goat Life Technologies WB 
    422 
5. Conclusions 423 
MT-1 isoform expression has been characterised in normal human urothelium for the first time, 424 
and a unique expression profile described with the use of isoform-specific antibodies. Individual 425 
MT-1 genes demonstrated inducer-specific expression and two paralogues with cadmium-specific 426 
or -selective induction were identified as candidate biomarkers of cadmium exposure.  With the 427 
potential for cadmium to interfere and substitute in the homeostatic regulation of zinc, new 428 
approaches are proposed for understanding cadmium-induced non-genotoxic carcinogenesis.  429 
 430 
Supplementary Materials: Supplementary materials can be found at www.mdpi.com/xxx/s1. 431 
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Abbreviations 441 
HMOX1 Heme oxygenase-1 
MT Metallothionein 
NHU Normal human urothelial 
SLC30A1 
TEER 
Solute carrier family A member 1 
Trans-epithelial electrical resistance  
 442 
Appendix A 443 
Supplementary Table 1: TEER readings from different NHU cell lines used for experiments. Each 444 
reading is an average of three technical replicates. A TEER reading >0.5 kA?.cm2 is considered to reflect 445 
a functional urothelial barrier. 446 
Cell Line Figure Time Point TEER (kȍ.cm2) 
   Control Cadmium 
Y1456 1B, Suppl. 12h 3.54 4.88 
  24h 3.58 3.96 
  48h 4.63 2.14 
  72h 3.78 4.09 
Y1493 Suppl. 24h 2.00 2.65 
  48h 3.20 2.99 
  72h 2.27 2.30 
Y1426 4C, Suppl. 72h 3.33 4.43 
 447 
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 448 
Supplementary Figure 1: RT-PCR showing MT isoform transcription in proliferating NHU cells 449 
exposed to cadmium (experimental replicate from Fig 2B). Non-differentiated NHU cells were 450 
exposed to 10 µM CdCl2 for up to 48 hours. The total cDNA input was 1 µg and PCR reaction products 451 
were removed after 25 cycles. 452 
 453 
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Supplementary Figure 2: RT-PCR showing MT isoform transcription in proliferating NHU cells 454 
exposed to cadmium (experimental replicate from Fig 2B). Non-differentiated NHU cells were 455 
exposed to 10 µM CdCl2 for up to 12 hours. The total cDNA input was 1 µg and PCR reaction products 456 
were removed after 25 cycles. 457 
 458 
Supplementary Figure 3: RT-PCR showing MT isoform transcription in cadmium-exposed 459 
differentiated NHU cell sheets that demonstrated a functional barrier (experimental replicate from 460 
Fig 2C). NHU cells were differentiated and exposed to 10 µM CdCl2 for up to 72 hours. Differentiation 461 
was confirmed using TEER readings and expression of KRT13. The total cDNA input was 1 µg and 462 
PCR reaction products were removed after 25 cycles. 463 
 464 
Supplementary Figure 4: RT-PCR showing MT isoform transcription in cadmium-exposed 465 
differentiated NHU cell sheets that demonstrated a functional barrier (experimental replicate from 466 
Fig 2C). NHU cells were differentiated and exposed to 10 µM CdCl2 for up to 72 hours. Differentiation 467 
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was confirmed using TEER readings and expression of ZO-1. The total cDNA input was 1 µg and 468 
PCR reaction products were removed after 25 cycles. 469 
 470 
Supplementary Figure 5: RT-PCR showing the effects of ROS on MT isoform transcription in NHU 471 
cells (experimental replicate from Fig 3C). The chemical Sulforaphane (C6H11NOS2) was used to 472 
induce ROS, having been titrated to a concentration that mimicked the levels of cadmium-induced 473 
ROS. Non-differentiated NHU cells were treated with either 10 µM CdCl2 or 5 µM C6H11NOS2 for 12 474 
hours. The total cDNA input was 1 µg and PCR reaction products were removed after 25 cycles. 475 
 476 
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Supplementary Figure 6: RT-PCR showing the effects of essential metal exposure on MT-1 isoform 477 
transcription in NHU cells (experimental replicate from Fig 3C). Non-differentiated NHU cells were 478 
exposed to either 10 µM CdCl2, 10 µM CuSO4, 10 µM FeSO4, or 10 µM ZnCl2 for 12 hours. The total 479 
cDNA input was 1 µg and PCR reaction products were removed after 25 cycles. 480 
 481 
Supplementary Figure 7: RT-PCR showing the effects of exposure to the carcinogenic metals arsenite 482 
and nickel on MT-1 isoform transcription in NHU cells (experimental replicate from Fig 3C). Non-483 
differentiated NHU cells were exposed to a range of concentrations of arsenite (0.25 µM Ȯ 2 µM; 484 
NaAsO2) and nickel (25 µM Ȯ 200 µM; NiCl2) for 12 hours. The total cDNA input was 1 µg and PCR 485 
reaction products were removed after 25 cycles. 486 
  487 
Supplementary Figure 8: Western blots showing MT-1A and MT-1M protein expression in non-488 
differentiated NHU cells exposed to cadmium (experimental replicate from Fig 4A). Non-489 
differentiated NHU cells (n=3) were exposed to 10 µM CdCl2 for 72 hours and protein expression of 490 
(A) MT-1A and (B) MT-1M determined using novel, isoform-ȱ ǯȱ A?-actin protein 491 
expression was used as a loading control. 492 
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 493 
Supplementary Figure 9: Western blots demonstrating MT-1A and 1M protein expression in 494 
differentiated NHU cells with functional barriers that were exposed to cadmium (experimental 495 
replicate from Fig 4B). NHU cells were stimulated to differentiate and form a functional barrier, before 496 
exposure to 10 µM CdCl2. (A) MT-1A protein expression was assessed at multiple time-points to 497 
ensure exposure time was adequate for protein translation in differentiated NHU cells. (B) Western 498 
blots showing MT-1A and MT-1M protein expression and (C) MT-1A protein expression in 499 
differentiated NHU cells exposed to cadmium foȱŝŘȱǯȱA?-actin protein expression was used as a 500 
loading control. 501 
 502 
Supplementary Figure 10: Western blot showing the specificity of cadmium-induced MT-1A and MT-503 
1M isoform protein expression in NHU cells (experimental replicate from Fig 4C). Non-differentiated 504 
NHU cells were exposed to a range of potential inducers for 72 hours. Candidate inducers were 505 
cadmium (10 µM CdCl2), copper (10 µM CuSO4), iron (10 µM FeSO4), zinc (10 µM ZnCl2), arsenite (2 506 
µM NaAsO2), nickel (200 µM NiCl2), and sulforaphane (5 µM C6H11NOS2). Cadmium in combination 507 
with ascorbic acid (25 µg/ml C6H8O6) was also included, to support the RT-PCR data demonstrating 508 
that inhibition of cadmium-induced ROS did not inhibit cadmium-induced MT expression (Fig 3C). 509 
A?-actin protein expression was used as a loading control. 510 
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 511 
Supplementary Figure 11: Effect of cadmium exposure on zinc transporter-1 (SLC30A1) transcription 512 
(experimental replicate from Fig 5B). RT-PCR of SLC30A1 gene transcription in non-differentiated 513 
NHU cells exposed to 10 µM CdCl2 for 3 or 7 days. Note that medium was changed at time T=0 and 514 
that for 3 day exposure there was no renewal of the cadmium by medium change over the period. For 515 
7 day exposure, cadmium-containing medium was renewed on day 4. The total cDNA input was 1 516 
µg and PCR reaction products were removed after 25 cycles. 517 
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